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NrCAM is a neural cell adhesion molecule of the L1 family that has been linked to autism spectrum disorders, a disease spectrum in which
abnormal thalamocortical connectivity may contribute to visual processing defects. Here we show that NrCAM interaction with
neuropilin-2 (Npn-2) is critical for semaphorin 3F (Sema3F)-induced guidance of thalamocortical axon subpopulations at the ventral
telencephalon (VTe), an intermediate target for thalamic axon sorting. Genetic deletion of NrCAM or Npn-2 caused contingents of
embryonic thalamic axons to misproject caudally in the VTe. The resultant thalamocortical map of NrCAM-null mutants showed striking
mistargeting of motor and somatosensory thalamic axon contingents to the primary visual cortex, but retinogeniculate targeting and
segregation were normal. NrCAM formed a molecular complex with Npn-2 in brain and neural cells, and was required for Sema3F-
induced growth cone collapse in thalamic neuron cultures, consistent with a vital function for NrCAM in Sema3F-induced axon repulsion.
NrCAM-null mice displayed reduced responses to visual evoked potentials recorded from layer IV in the binocular zone of primary visual
cortex (V1), particularly when evoked from the ipsilateral eye, indicating abnormal visual acuity and ocularity. These results demonstrate
that NrCAM is required for normal maturation of cortical visual acuity, and suggest that the aberrant projection of thalamic motor and
somatosensory axons to the visual cortex in NrCAM-null mutant mice impairs cortical functions.
Introduction
Neuron-glial-related cell adhesion molecule (NrCAM) is mem-
ber of the L1 family [L1, close homolog of L1 (CHL1), NrCAM,
neurofascin], which function in development of neural connec-
tivity (Maness and Schachner, 2007). The NrCAM gene at chro-
mosome 7q31 is one of 100 candidate genes implicated in
autism spectrum disorders (ASDs) (Pinto et al., 2010). NrCAM
polymorphisms are associated with ASD subpopulations with
obsessive-compulsive behavior, and with mathematical ability
(Docherty et al., 2010). NrCAM-null mice (Sakurai et al., 2001)
provide a model for investigating effects of NrCAM deletion on
neural circuitry relevant to ASDs. Deletion of NrCAM causes
impaired sociability, visual-spatial learning, and sensory gating
(Moy et al., 2009b), as well as impulsivity (Matzel et al., 2008) and
altered drug reward (Ishiguro et al., 2006). Sensory disturbances
in the motor, tactile, and visual systems are common in ASDs and
can be manifested in hyper- or hyposensitive responses (Matzel et al.,
2008; Baron-Cohen et al., 2009). As most sensory input to the cortex
is relayed through the thalamus, thalamocortical circuitry may be
perturbed in ASDs. Indeed, MRI studies in autistic patients show
widespread thalamocortical disconnectivity affecting visual
and sensorimotor systems (Mizuno et al., 2006; Takarae et al.,
2007; Mostofsky et al., 2009) and diminished thalamic activity
(Hardan et al., 2008).
Accurate topographic targeting of thalamocortical axons
from distinct thalamic nuclei to specific neocortical areas is es-
sential for visual cortical function and other sensory modalities.
Each projection is topographically organized along rostrocaudal
and mediolateral cortical axes (Caviness and Frost, 1980; Lopez-
Bendito and Molnar, 2003), which, in the visual cortex, enables
visual images to be faithfully represented (Cang et al., 2008). The
ventral telencephalon has emerged as an intermediate target
where thalamic axons are sorted toward appropriate cortical ar-
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eas by gradients of ephrinAs, netrin-1, and semaphorin 3A (Du-
four et al., 2003; Bonnin et al., 2007; Powell et al., 2008). CHL1
interaction with neuropilin-1 mediates semaphorin 3A-induced
guidance of thalamic axons to the somatosensory cortex
(Wiencken-Barger et al., 2004; Wright et al., 2007; Demyanenko
et al., 2010), and cooperates with L1 in thalamic axon targeting to
the motor cortex (Demyanenko et al., 2010). Although NrCAM
plays a role in patterning of the binocular visual pathway, direct-
ing retinal axons across the optic chiasm (Williams et al., 2006), a
function in thalamocortical axon guidance has not been investi-
gated. NrCAM differs from other L1 members in mediating re-
pellent responses to neuropilin-2 (Falk et al., 2005) and having a
PDZ binding site (Davey et al., 2005; Dirks et al., 2006). Hence,
NrCAM might control topographic mapping of thalamic axon
subpopulations by a distinct mechanism, and its loss might per-
turb synaptic targeting in the visual cortex.
We demonstrate that NrCAM mediates repellent guidance to
semaphorin 3F (Sema3F) in the ventral telencephalon (VTe)
through neuropilin-2 (Npn-2), and that NrCAM deficiency
causes mistargeting of motor and somatosensory thalamic axon
subpopulations to the visual cortex. Decreased responses to vi-
sual evoked potentials (VEPs) recorded from layer IV in the bin-
ocular zone of NrCAM-null mice suggest that misprojection of
thalamic axons to the visual cortex arising from NrCAM loss can
affect visual cortical responses such as acuity or binocular vision.
Materials and Methods
Mice. Wild-type (WT) and homozygous-null NrCAM mutant mice
(Sakurai et al., 2001; Ishiguro et al., 2006) were provided by Dr. Martin
Grumet (Rutgers University, Piscataway, NJ). These mice were generated
by homologous recombination, deleting the fourth exon to remove the
translation initiation codon and signal sequence. Homozygotes express
no detectable NrCAM protein (Sakurai et al., 2001). Mice on a mixed
129S6/SvEvTac (129S6)  Swiss Webster (CFW) background were back-
crossed to C57BL/6 for 7 generations. For our studies, heterozygotes were
intercrossed to obtain homozygous NrCAM-null mutants and WT lit-
termates. Neuropilin-2-null mutant mice on a C57BL/6 background
were described previously (Giger et al., 2000; Walz et al., 2002), and were
generated by intercrossing heterozygotes. E0.5 was defined as the plug
date and postnatal day 0 (P0) as day of birth. Animal care and treatment
were in accordance with guidelines of the University of North Carolina
Institutional Animal Care and Use Committee.
Immunostaining, histology, and immunoblotting. Brains were perfused
with 4% paraformaldehyde (PFA) and postfixed in 4% PFA, then vi-
bratome sectioned at 60 m. Sections were stained with purified NrCAM
rabbit polyclonal IgG (Lustig et al., 2001) (Abcam, ab24344; 1:300) and
fluorescein isothiocyanate (FITC)- or tetramethylrhodamine isothiocya-
nate (TRITC)-conjugated secondary antibodies, and imaged by confocal
microscopy as described previously (Wright et al., 2007). For immuno-
histochemistry, cortical hemispheres were flattened and horizontally sec-
tioned. Sections were then incubated with rabbit polyclonal antibody
against serotonin [5 hydroxytryptamine (5-HT), 1:50,000; Immunostar,
Inc] for 48 h, then with biotinylated anti-rabbit IgG (Jackson Immu-
noResearch Laboratories, Inc). 5-HT immunoreactivity was detected us-
ing an Elite ABC Kit and Peroxidase Substrate Kit (Vector Laboratories).
For histology, brains were processed for Nissl as described previously
(Demyanenko et al., 1999). For embryonic thalamic neuron cultures the
following antibodies were used: anti-rat Npn-2 (R&D Systems; AF567),
1:150; TuJ1 monoclonal antibody (Covance; MMS-435P), 1:500; nestin
monoclonal antibody (Developmental Studies Hybridoma Bank),
1:1000; and glial fibrillary acidic protein polyclonal antibody (DAKO),
1:250. Immunoblotting was performed as described previously (Wright
et al., 2007).
In situ hybridization. Digoxigenin-labeled riboprobes for NrCAM
were generated by in vitro transcription from a pBlueScript plasmid con-
taining mouse NrCAM cDNA (AJ543321; nucleotides 460 –1470), in-
cluding 9 bases from the 5 untranslated region. Plasmid pmNrCAM was
linearized with EcoRI and transcribed with T7 RNA polymerase for the
antisense probe, or with BamHI and transcribed with T3 RNA polymer-
ase for the sense probe, according to manufacturer’s protocol (Roche).
Digoxigenin-labeled riboprobes for Sema3F (gift from Dr. David Ginty,
Johns Hopkins University School of Medicine and Howard Hughes
Medical Institute, Baltimore, MD) were generated from the pBS KS vec-
tor (Giger et al., 1998). Pixel densities were measured using ImageJ soft-
ware to assess gradient expression of Sema3F mRNA. In situ
hybridization (ISH) was performed in the histology core facility of the
Neuroscience Center of University of North Carolina at Chapel Hill.
Brains from WT embryos (E14.5) were immersion fixed in 4% PFA
overnight and cryoprotected in sucrose before sectioning horizontally.
ISH was performed as described previously (Colbert et al., 1995) and
images were captured digitally on a Zeiss Axioplan 2 microscope.
Thalamocortical axon tracing. Retrograde tracing of thalamocortical
axons from the cortex was performed by focal injection of 1,1-di-
octadecyl-3,3,3–3-tetramethylindocarbocyanine perchlorate (DiI) and
4,4-dihexadecyl aminostyryl N-methylpyridinium iodide (DiA) (In-
vitrogen) (5–10% in N, N-dimethylformamide) in one or two distinct
cortical areas of living P5 mice anesthetized by hypothermia. Injections
were made with capillary micropipettes connected to a Picospritzer II.
Mice were fixed by transcardial perfusion with 4% paraformaldehyde
48 h later. Forebrains were vibratome sectioned in the coronal plane (100
m). Injection sites were monitored microscopically and only those in-
jections restricted to the neocortex, without entering the white matter,
were analyzed. The location and position of injection sites, and posi-
tion of thalamic nuclei were identified by DAPI (4,6-diamidino-2-
phenylindole dihydrochloride) nuclear staining and comparison to atlas
coordinates (Franklin and Paxinos, 1997). Cortical injections of DiI/DiA
in live postnatal mice predominantly label thalamocortical axons by ret-
rograde tracing from layer IV with minimal anterograde labeling of cor-
ticofugal axons (Dufour et al., 2003; Torii and Levitt, 2005; Wright et al.,
2007; Little et al., 2009; Demyanenko et al., 2010).
For anterograde tracing, brains of WT, NrCAM, and Npn-2 mutant
embryos (E15.5) were fixed in 4% PFA overnight at 4°C. After hemidis-
section, crystals of DiA (rostral) or DiI (caudal) were inserted into the
dorsal thalamus (DT). After diffusion for 2– 4 weeks at room tempera-
ture, brains were vibratome sectioned (100 m) in the coronal plane.
Sections were mounted in Vectashield and imaged using epifluorescence
or confocal microscopy. The size and position of the crystals with respect
to the thalamic eminence (TE), where axons leave the diencephalon and
enter the VTe, were verified microscopically. Acceptable injections were
within 100 m of the TE for the rostral DT and 300 m for the caudal
DT. The data were analyzed as reported previously (Dufour et al., 2003;
Wright et al., 2007). Data were graphed with the x-axis depicting the
position of labeled axons in sections along the rostrocaudal axis of the
ventral or dorsal telencephalon relative to the first section of the TE (0
m). Because of slight differences in total number of sections among
hemispheres, section numbers were normalized with respect to the dis-
tance from the TE (0 m). The y-axis (frequency) represented the per-
centage of hemispheres containing DiI-labeled axons for each genotype.
The normalized section number exhibiting the greatest frequency of la-
beled axons was set at 100% for each genotype. The distance (m) of the
caudal-most labeled section from the TE was determined for each case,
then means were calculated and compared by Student’s t test ( p  0.05).
Growth cone collapse assay. Dissociated cultures of thalamic embryonic
(E14.5) neurons were prepared from WT and NrCAM-null littermates as
described previously (Demyanenko et al., 2010), plated in fibronectin-
coated Lab-Tek chamber slides in 10% fetal bovine serum and DMEM,
and the next day the medium was changed to Neurobasal medium with
B27 supplement and glutamate (25 M). Marker immunostaining after
1 d in culture showed that these cultures contained 60% Tuj1-posi-
tive neurons, 50% nestin-positive immature neurons, and 40% glial
fibrillary associated protein-positive glia. Only the TuJ1-positive cells
had typical neuronal morphology with multiple processes tipped by large
growth cones emerging from cell bodies. After 42 h, cells were treated
with normal human IgG or Sema3F fused to human Fc (Sema3F-Fc;
R&D Systems) (30 nM) for 30 min. Cells were fixed with 4% paraformal-
1546 • J. Neurosci., January 26, 2011 • 31(4):1545–1558 Demyanenko et al. • NrCAM in Thalamocortical Axon Targeting
dehyde and permeabilized with 0.2% Triton X-100 for 5 min. After washing,
cells were treated with rhodamine-conjugated phalloidin (Invitrogen;
1:40) for 30 min to visualize F-actin in the growth cone. Cells were
mounted in Vectashield and growth cone morphology was scored under
epifluorescent illumination. Only cells with neuronal morphology in-
cluding multiple processes were analyzed. Growth cones were scored as
collapsed if they had a bullet-shaped morphology, and uncollapsed if
they were well spread with numerous filopodia as described previously
(Demyanenko et al., 2010).
Cell surface coclustering of NrCAM and neuropilin-2. Cell surface co-
clustering was performed as previously reported for CHL1 and Npn-2
(Wright et al., 2007). The mouse neuroblastoma cell line Neuro2A was
plated on fibronectin and poly-D-lysine-coated Lab-Tek dishes in
DMEM-10% calf serum (CS). These cells express NrCAM, Npn-2, and
PlexinA3 by Western blotting (data not shown). To cluster surface
Npn-2, cells (10,000 cells) were incubated with Npn-2 goat polyclonal
antibody AF567 (40 g/ml; R&D Systems) against extracellular determi-
nants at 4°C for 20 min, washed in ice-cold DMEM-HEPES without CS,
then incubated with mouse anti-goat IgG (10 g/ml) in DMEM-25 mM
HEPES for 30 min on ice (4C). After washing with DMEM, cells were
incubated in DMEM-10% CS for 1 h at 37°C then fixed with 4% PFA for
15 min. After washing, cells were blocked in 10% donkey serum for 1 h at
room temperature, and incubated with NrCAM rabbit polyclonal anti-
body (10 g/ml) against extracellular determinants for 1 h. As control,
normal goat IgG (40 g/ml) in DMEM-10% CS and normal rabbit IgG
(10 g/ml) in 10% normal donkey serum were substituted. All cells were
incubated with FITC 488-DyLight donkey anti-mouse IgG (Jackson Im-
munoResearch Laboratories, Inc) and TRITC-donkey anti-rabbit IgG
(Jackson ImmunoResearch Laboratories, Inc) (1:100) for 1 h, washed,
and mounted in Vectashield. Cells were imaged using Zeiss 510 confocal
microscope, and scored for clustering of Npn-2 and NrCAM into patches
or caps in merged images. The percentage of Npn-2-positive cells exhib-
iting coclustering of NrCAM in patches and/or caps was quantified.
Coimmunoprecipitation. Brains of WT embryos (E15.5) were lysed in
radioimmunoprecipitation assay buffer [20 mM Tris, pH 7.0, 0.15 M
NaCl, 5 mM EDTA, 1 mM EGTA, 1% Nonidet P-40, 1% deoxycholate,
0.1% SDS, 200 M Na3VO4, 10 mM NaF, 1 protease inhibitors
(Sigma)], clarified by centrifugation, and protein concentration was de-
termined by bicinchoninic acid (ThermoFisher Scientific). NrCAM was
imunoprecipitated from 1 mg of brain homogenate using NrCAM IgG (1
g) and protein A/G agarose. Nonimmune rabbit IgG was used as a control.
Immunoprecipitated proteins and brain lysates (75 g) were separated by
SDS-PAGE, transferred to nitrocellulose, and Western blotted using Npn-2
(1:500) or NrCAM (1:500) antibodies. Blots were developed using enhanced
chemiluminescence (ThermoFisher Scientific) and exposed to film.
Labeling and quantification of retinogeniculate projections. WT and
NrCAM-null littermates (P10) were anesthetized with isoflurane, and
injected with Alexa Fluor 488-conjugated cholera toxin subunit B in one
eye and Alexa Fluor 594-conjugated cholera toxin subunit B in the other
eye (Alexa fluors; Invitrogen). At P12, mice were perfused with 4% para-
formaldehyde; brains were sectioned at 100 m, and mounted. Fluores-
cent images of brain sections containing the dorsal lateral geniculate
nucleus (dLGN) were examined on a Zeiss Axioplan microscope, and
captured using universal gains and exposures on a Zeiss Axiocam color
CCD camera. Unmodified images of the dLGN were analyzed in Adobe
Photoshop using the multithreshold protocol used by (Stevens et al.,
2007) based on the methods described by Torborg et al. (2005). The
multithreshold protocol provides a range of signal to background levels
for analysis of the size of the ipsilateral axon area (termed “ispilateral
patch”) relative to the total size of the dLGN, as well as any overlap
between the ipsilateral patch and the contralateral axon targeting area in
the dLGN. The pixel areas of the modified images were measured in
ImageJ for each threshold level, delivering values for both ipsilateral and
overlap area. Total dLGN area was measured by selecting the unmodified
contralateral image in ImageJ and measuring total area. Mean ipsilateral
area/dLGN area for each genotype was compared at each threshold level
by t test ( p  0.05). The distance of the lateral border of the ipsilateral
patch at its widest portion from the lateral border of the dLGN was
measured and expressed as a percentage of the width of the dLGN at the
same location. The length of the ipsilateral patch from the dorsomedial to
ventrolateral border was expressed as a percentage of the length of the
dLGN. Means were compared by the t test ( p  0.05).
Visual evoked potential recording. Male and female mice (P27) were
anesthetized with ketamine/xylazine (120 mg:9 mg/kg) and 0.25% bu-
pivacaine (Hospira) applied as a local anesthetic to the scalp incision site.
Tungsten microelectrodes (FHC) with impedances of 0.3– 0.5 M were
implanted in the binocular visual cortex [3.0 mm mediolateral (ML) to
lambda, and 0.42 mm dorsoventral to brain surface). Recording elec-
trodes, silver reference electrodes (2.0 mm ML, 1.0 mm anteropos-
terior to bregma, placed on brain surface), and holding post (resting on
the skull surface anterior to bregma) were all secured to the skull with
cyanoacrylic (Henkel). Mice were habituated to the restraint device 24 h
before the recording session at P27. All recordings were performed blind
to genotype. Awake mice were placed 20 cm from a 21 inch cathode ray
tube monitor (63 cd/m 2) and presented with 160 visual stimuli per con-
dition. A trough to peak VEP amplitude was determined from the aver-
aged visual response. Monocular and binocular visual stimuli consisted
of full-field square counterphase sine gratings (45° or 135°) of 0.05 cycles/
degree (cpd) and 0.3 cpd at 100% contrast (Vision Research Graphics).
All recordings were amplified 1000, and high and low band filters set to
0.1 Hz and 100 Hz, respectively (Grass Instruments). Data were digitized
and acquired in Spike2 (Cambridge Electronic Design).
Results
NrCAM is expressed in the developing
thalamocortical pathway
To investigate the role of NrCAM during development of the
topographic thalamocortical axon projection, NrCAM expres-
sion was analyzed by immunostaining at embryonic days 14.5
(E14.5) and E16.5, and at P5 (Fig. 1A–E). From E14.5-16.5, tha-
lamic axons navigate from the DT through the VTe en route to
the cortex. At E14.5 and E16.5, NrCAM was robustly expressed
on fibers within the DT and crossing the VTe (Fig. 1 A, D).
NrCAM was also expressed in the cortex, where it was most evi-
dent within the intermediate zone (IZ) and marginal zone (MZ),
with low levels in the ventricular zone (VZ) (Fig. 1B,E). NrCAM
expression was prominent in the cortex at P5, where it was pre-
dominant in deep layers (IV-VI) (Fig. 1F). No labeling was ob-
served with nonimmune IgG, as shown at E14.5 in the cortex (Fig.
1C). Immunoblotting for NrCAM in lysates of mouse forebrain
confirmed its expression from E16.5 through P5, and showed
persistently elevated levels at later stages of maturation (Fig. 1G).
NrCAM antibodies recognized the major 140 kDa NrCAM protein,
corresponding to furin-cleaved NrCAM, and its 60 kDa fragment in
brain (Sakurai et al., 2001; Conacci-Sorrell et al., 2005). Full-length
NrCAM (200 kDa) protein is rarely observed except in transfected
cells (Sakurai et al., 1997; Conacci-Sorrell et al., 2005).
In situ hybridization to detect NrCAM mRNA was performed
on serial horizontal sections through the DT of E14.5 and E16.5
embryos, and P5 mice (n  3 per stage). Results showed that
NrCAM transcripts were differentially expressed along both
rostrocaudal and dorsoventral axes of the embryonic DT (Fig.
1 H–L). Although thalamic nuclei are not fully developed or
identifiable in E14.5-E16.5 embryos, NrCAM transcripts were
more abundant in discrete regions of the rostral DT, where anlage
of the ventroanterior (VA) and ventrolateral (VL) thalamic nu-
cleus arise, as well as in more caudolateral regions of the DT (Fig.
1H,K, arrows). Notably, NrCAM was not expressed in cells
within the VTe. This pattern of NrCAM transcripts was different
from but partly overlapping with that of L1 (Demyanenko et al.,
2010) and CHL1 (Wright et al., 2007) in the developing DT. High
levels of NrCAM transcripts were also evident in the dorsal tel-
encephalon (DTe, cortex) at E14.5-E16.5, most prominently in
the cortical plate (CP) (Fig. 1 I,K). Control staining with a sense
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probe generated from the same plasmid
showed no labeling at E14.5 (Fig. 1 J) or
other stages. At P5, NrCAM mRNA was
observed at highest levels in deep layers of
the neocortex and in the hippocampus,
but at low levels in the DT (Fig. 1L).
NrCAM is required for correct
topography of thalamocortical
projections to motor and
somatosensory cortical areas
Topography of thalamocortical projec-
tions is organized such that rostromedial
thalamic neurons project to more rostral
areas of the neocortex and caudolateral
thalamic neurons project to more caudal
areas (Caviness and Frost, 1980). To in-
vestigate a role for NrCAM in thalamo-
cortical axon targeting, the projections of
thalamic axons were analyzed by retro-
grade tracing from primary motor and
sensory neocortical areas to different DT
nuclei in WT and NrCAM-null littermates
at P7, when thalamocortical topographic
connectivity is completed (Agmon et al.,
1995). Carbocyanine dyes (DiI or DiA)
were singly or dually injected into the pri-
mary visual (V1), somatosensory (S1), or
motor (M1) cortex of live, anesthetized P5
mice, and analyzed at P7. DiI/DiA injec-
tions into different cortical areas labeled
the cell bodies of thalamic neurons in DT
nuclei by retrograde tracing, as documented
in supplemental Figure 1N (available at
www.jneurosci.org as supplemental ma-
terial). Injections of DiI/DiA were care-
fully screened for restricted localization
within the cortical plate and absence from
the white matter. Injections (single or
dual) into V1 of WT mice labeled cells in
the dLGN (10 of 10 injections) but not in
other DT nuclei, such as the VL or ventro-
basal (VB) nuclei (Fig. 2C,D; supplemen-
tal Fig. 2A–I, available at www.jneurosci.
org as supplemental material). Injections
of DiI into M1 of WT mice labeled only
VA and VL nuclei (13 of 13) (Fig. 2E).
Injections into S1 of WT mice labeled only
VB nuclei (13 of 13). Dual injection of
DiA into S1 and DiI into V1 specifically
labeled VB (green) or dLGN (red) nuclei,
respectively, with no mixing of labels (Fig.
2F). WT thalamocortical axonal trajecto-
ries are summarized in Figure 2A.
In NrCAM-null mutant mice injec-
tions into V1 resulted in inappropriate la-
beling of VA and/or VL (12 of 19) (Fig.
2H, I; supplemental Fig. 1C–H, available
at www.jneurosci.org as supplemental
material) as well as VB nuclei (16 of 19) (Fig. 2 J; supplemental
Fig. 1 J, available at www.jneurosci.org as supplemental material).
In addition, normal labeling was observed in the dLGN (19 of 19)
(Fig. 2 J,O; supplemental Fig. 1 J,L, available at www.jneurosci.
org as supplemental material). Injections into M1 of NrCAM-
null mutants always resulted in normal labeling of VA/VL nuclei
(19 of 19) (Fig. 2K). Dual injection of DiA into M1 and DiI into
V1 resulted in appropriate DiA labeling (green) and inappropri-
Figure 1. NrCAM is expressed in the developing thalamocortical pathway. A, Immunofluorescence staining for NrCAM in a
midcoronal section (to best observe the entire thalamocortical pathway) of WT mouse embryonic brain (E14.5) during projection
of thalamic axons to the neocortex visualized by confocal microscopy. NrCAM protein was evident in the DT, VTe, IZ, MZ, and CP. B,
NrCAM localization in the visual cortex of WT embryos (E14.5). NrCAM staining was most prominent in the IZ and MZ, with lower
levels in the VZ. C, No staining was observed with nonimmune IgG (control) (E14.5). D, Immunofluorescence staining for NrCAM in
a mid-coronal section of E16.5 WT brain visualized by confocal microscopy. NrCAM protein is prominent in the DT and VTe, and is
also present in IZ and CP. E, NrCAM localization in the visual cortex of WT mouse embryonic brain (E16.5) visualized by confocal
microscopy. NrCAM staining was most prominent in fibers crossing the VTe, and in the cortical IZ and MZ. F, NrCAM localization in
the visual cortex of postnatal WT mice (P5). NrCAM staining was prominent in all cortical layers with highest levels in deep layers
(IV–VI). G, Expression of NrCAM (major 140 kDa form and minor 60 kDa cleavage fragment) during development as shown by
immunoblotting of WT mouse forebrain lysates (50 g) at embryonic, postnatal and adult stages. H, K, L, In situ hybridization
shows NrCAM transcripts in WT embryos (E14.5, E16.5, and P5) in serial horizontal sections (to best observe the DT) along the
dorsoventral axis. H, K, At E14.5 and E16.5 NrCAM transcripts were most abundant in discrete rostral and caudal regions of the DT
(arrows), and in the CP, but not in the VTe. Dashed lines delineate the caudal DT boundary. L, At P5 NrCAM transcripts were high in
the deep layers of the cortex and in the hippocampus, and low in the DT. I, NrCAM transcripts in the visual cortex (E14.5) showed
highest levels in the deep CP. J, No labeling at E14.5 was obtained using the control sense riboprobe. Cx, cerebral cortex; HC,
hippocampus; SVZ, subventricular zone. Scale bars: (A, D, H, J–L), 500 m; (B, E, F ), 100 m; (I ), 50 m.
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Figure 2. Projections of motor and somatosensory thalamic axons misproject caudally to the visual cortex in NrCAM-null mutant mice (P5). A, Scheme illustrating the final thalamocortical map
in WT mice (P5). Axons from VA/VL DT nuclei project to M1; axons from VB project to S1; axons from the dLGN project to V1. The orientation of all images in Figure 2 are indicated in A (R, rostral; L,
lateral). Injection site and section plane of each image are schematically illustrated. B–D, Retrograde axon tracing in WT mice following injection of DiI into V1 at P5 and analysis at P7. B, DiI injection
site in V1 for experiment shown in C and D. C, No labeling of cell soma in VL. D, Appropriate labeling of cell soma in the dLGN and no labeling of VB nuclei. E, Retrograde axon tracing in WT mice (P5)
following injection of DiI into M1 shows appropriate labeling of cell soma in VA/VL nuclei. F, Retrograde axon tracing in WT mice (P5) following dual injections of DiA into S1 and DiI into V1 shows
appropriate labeling of cell soma in the VB and dLGN, respectively. G, Scheme illustrating altered thalamocortical topography in NrCAM-null mutant mice (P5). Contingents of thalamocortical axons
from VA/VL and VB nuclei project inappropriately to V1, while some contingents project normally to M1 and S1. dLGN axons project appropriately to V1. H–J, Retrograde axon tracing in NrCAM-null
mutant mice following injection of DiI into V1 at P5 and analysis at P7. H, DiI injection site in V1 for experiment shown in I and J. I, Inappropriate labeling of cell soma located within VL. J, Appropriate
labeling of cell soma located within the dLGN and inappropriate labeling of cell soma in VB nuclei. K, Retrograde axon tracing in NrCAM-null mice (P5) following DiA (Figure legend continues.)
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ate DiI labeling (red) of VA/VL nuclei (Fig. 2L). Single injections
into S1 (Fig. 2N) resulted in normal labeling of only VB nuclei
(15 of 15) (Fig. 2M). Dual injection of DiA into S1 and DiI into
V1 resulted in appropriate DiA labeling (green) of VB, but inap-
propriate DiI labeling (red) of VB (Fig. 2O) and VA/VL (Fig. 2P).
This confirmed the inappropriate labeling of VB and VA/VL re-
sulting from single V1 injections. Single axons from dual injec-
tions were not double-labeled, indicating that mistargeting of
mutant axons did not arise from axon collaterals. Chi Square
analysis confirmed that there were significant differences in the
misprojection of NrCAM-null mutant axons from VA/VL to V1
( 2  10.77, p  0.01) and from VB to V1 ( 2  18.78, p 
0.001), but not in any other case ( 2 undefined).
Although NrCAM can bind heterophilically to neurofascin,
another L1-CAM family member (Volkmer et al., 1996; Pruss et
al., 2004) expressed in the thalamocortical pathway, retrograde
axon tracing in neurofascin-null mutant mice (P5) revealed no
deviations in the projections of thalamic axons retrogradely
traced by DiI or DiA injections into S1 (10 of 10), V1 (4 of 4) (Fig.
2R,S), or M1 (4 of 4) (Fig. 2R,S). Thus, the thalamocortical axon
mapping defects observed in NrCAM-null mutants were not re-
capitulated in neurofascin mutants, suggesting that the topogra-
phy of these projections most likely does not depend on NrCAM
interactions with neurofascin.
In conclusion (Fig. 2G), results of retrograde axon tracing exper-
iments in NrCAM-null mutant mice (P5) suggested that loss of Nr-
CAM causes a subset of thalamic axons from motor and
somatosensory nuclei to shift caudally and inappropriately target the
visual cortex.
NrCAM is required for guidance of thalamic axon
subpopulations at the ventral telencephalon
To investigate whether the observed mistargeting was due to mis-
guidance of TC axons at the intermediate axon sorting target, the
VTe, anterograde tracing of DT axons was performed in WT and
NrCAM-null mutant embryos (E15.5). After fixation, DiA was in-
jected into the rostral third of the DT, where VA/VL nuclei develop,
and DiI into the caudal third of the DT, where the dLGN arises (Fig.
3, schemes). After 4 weeks the distribution of axons in the VTe was
analyzed in serial sections along the rostrocaudal axis. Normally,
rostral DT axons project rostrally through the VTe, while caudal DT
axons project caudally (Dufour et al., 2006). At the TE, where
thalamocortical axons leave the diencephalon and enter the VTe,
labeled rostral (green) and caudal (red) DT axons were clearly seg-
regated in both WT and NrCAM-null embryos (Fig. 3A,D). No
differences were observed in axon fasciculation, or in segregation of
labeled rostral and caudal thalamocortical axons along the medio-
lateral axis of the VTe in NrCAM-null mutant embryos.
Within the VTe, rostral DT axons in NrCAM-null embryos
were shifted in the caudal direction compared with WT, as shown
by the presence of DiA-labeled axons in caudal sections of
NrCAM mutants (Fig. 3E) where labeled axons were not ob-
served in WT (Fig. 3B). The distribution of labeled rostral DT
axons present along the rostrocaudal axis of the VTe demon-
strated that NrCAM-null axons were shifted caudally (Fig. 3E–J).
The mean distance of caudal-most sections in the VTe containing
labeled rostral DT axons from the TE was significantly greater in
NrCAM mutants than WT, indicating that they were significantly
shifted in the caudal direction (Fig. 3E,G,H). Axons from the
rostral DT that had arrived in the dorsal telencephalon of
NrCAM-null embryos (E15.5) also displayed a significant caudal
shift in their distribution compared with WT (Fig. 3F, I,J), dem-
onstrating that misguidance was maintained in the developing
cortex. A similar analysis of DiI-labeled caudal DT axons showed
no significant differences in rostrocaudal distribution in the VTe
or cortex of NrCAM mutants at E15.5 compared with WT (data
not shown).
NrCAM colocalizes with the Sema3F receptor neuropilin-2 in
the thalamocortical pathway
To investigate whether NrCAM might cooperate with Npn-2 to
regulate thalamic axon responses to Sema3F, Npn-2, and Sema3F
expression was analyzed in WT embryos during the major period
of thalamocortical axon outgrowth (E14.5). Double immuno-
staining in rostral sections through the DT showed that Npn-2
was prominently expressed in the DT and colocalized extensively
with NrCAM (Fig. 4A–I). NrCAM and Npn-2 were present on
cells (Fig. 4D–F) and fibers (Fig. 4G–I) and largely colocalized in
the rostral DT except in the extreme medial area (Fig. 4D–F). In
more caudal sections (Fig. 4 J–L) NrCAM and Npn-2 were less
highly expressed in the DT (Fig. 4 J–L), but clearly colocalized on
DT axons, where they emerged from the TE and navigated across
the VTe (Fig. 4M–O, arrows). The expression of Sema3F, a prin-
cipal ligand for Npn-2, was evaluated by in situ hybridization in
WT E14.5 embryos. Sema3F transcripts were abundant in the
VTe (Fig. 4P). Sema3F transcripts were also evident in the cortex,
especially in the CP (Fig. 4Q). Control labeling with the sense
probe was low in both VTe and cortex (Fig. 4R). The observed
pattern of Sema3F mRNA expression was in accord with studies
in developing rat VTe and cortex (Tamamaki, 2002). Impor-
tantly, measurement of pixel density revealed an ascending ros-
trocaudal gradient of Sema3F mRNA in the VTe (Fig. 4S). Thus,
the gradient of Sema3F in the VTe of E14.5 embryos could po-
tentially function to repel thalamic axons expressing NrCAM and
Npn-2 from caudal regions of the VTe.
Neuropilin-2 mediates guidance of thalamic axons in the
ventral telencephalon
To investigate whether Npn-2 was involved in thalamocortical
axon guidance, thalamic axons were anterogradely labeled in ho-
mozygous Npn-2-null mutant embryos (E15.5) by injecting DiA
into the rostral DT and DiI into the caudal DT after fixation (Fig.
5 schemes). Rostral and caudal DT axons were clearly segregated
as they emerged from the TE in both Npn-2 heterozygous con-
trols and Npn-2-null embryos, and showed no evidence of al-
tered fasciculation (Fig. 5A,D). Analysis of the distribution of
labeled axons in the VTe revealed that rostral DT axons in Npn-
2-null embryos were shifted caudally compared with Npn-2 het-
erozygotes, as shown by the presence of DiA-labeled axons in
more caudal sections of Npn-2 mutants (Fig. 5E), and by the
caudal shift in distribution of rostral DT axons in VTe (Fig.
5G,H) and DTe (Fig. 5F, I,J). The mean distance of caudal-most
sections containing labeled rostral DT axons in the VTe was sig-
4
(Figure legend continued.) injection into M1 shows normal labeling of VA/VL. L, Retrograde
axon tracing in NrCAM-null mice (P5) following dual injections of DiA into M1 and DiI into V1
shows appropriate DiA labeling of cell soma in VA/VL and inappropriate DiI labeling of VA/VL. M,
Retrograde axon tracing in NrCAM-null mutants (P5) following DiI injection into S1 shows
normal labeling of VB and no labeling of dLGN. N, DiI injection site in S1 for experiment shown
in M. O, P, Retrograde axon tracing in NrCAM-null mice (P5) following dual injections of DiA into
S1 and DiI into V1 shows inappropriate DiI labeling of cell soma in VB (O, P) and VA/VL (P), as
well as appropriate DiI labeling of dLGN (O) and DiA labeling of VB (O). Q–S, Retrograde axon
tracing in Neurofascin-null mutant mice (P5) following dual injections of DiA into S1 and DiI into
V1 shows appropriate labeling of VB (R) and dLGN (S). l, lateral; m, medial; VPL, ventroposterior
lateral; VPM, ventroposterior medial. Scale bars, 500 m in all panels.
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nificantly greater in Npn-2 mutants than Npn-2 heterozygote
controls (Fig. 5E,G,H). The small rostral shift of labeled rostral
DT axons in Npn-2 mutants was not significant. Analysis of DiI-
labeled caudal DT axons showed no significant differences in
distribution in either the VTe or cortex of Npn-2 mutants at
E15.5 (data not shown). Thus, Npn-2-null embryos (E15.5) ex-
hibited a phenotype of caudal misprojection of DT axons in the
VTe similar to that of NrCAM-null embryos, suggesting that
there may be important functional interactions between Npn-2
and NrCAM.
NrCAM mediates Sema3F-induced
growth cone collapse of thalamic
neurons and associates
with neuropilin-2
The posterior shift of motor and somato-
sensory thalamic axons to the visual cor-
tex in NrCAM-null mutants may be due
to impaired repellent of thalamic axon
guidance away from the high caudal
Sema3F gradient in the VTe, where axons
are sorted initially along the rostrocaudal
axis to discrete cortical areas (Dufour et
al., 2003). To determine whether NrCAM
is required for growth cone collapse in
thalamic axons in response to Sema3F,
growth cone collapse assays were performed
using cultures of dissociated thalamic neu-
rons from WT and NrCAM-null mutant
embryos (E15.5). Sema3F-Fc induced a
pronounced growth cone collapse response
in WT thalamic neurons, notably increasing
the percentage of collapsed growth cones
compared with control treatment with non-
immune IgG (Fig. 6A,B,F). In contrast,
Sema3F-Fc treatment of NrCAM-null mu-
tant thalamic neurons failed to induce
growth cone collapse compared with the
control treatment. Basal growth cone col-
lapse in the presence of nonimmune IgG
was equivalent for WT and NrCAM-null
neurons and was not different from un-
treated cultures (data not shown). NrCAM
was expressed in 58% of cells in the thalamic
cultures and colocalized with Npn-2 in 53%
of cells (n  62). NrCAM immunofluores-
cence was evident on cell bodies, processes
and growth cones of cells with neuronal
morphology and was enriched at tips of
filopodia (Fig. 6E).
A molecular complex of NrCAM and
Npn-2 (characteristic doublet) (Giger et
al., 2000) was demonstrated by coimmu-
noprecipitation from lysates of E15.5 mouse
brain (Fig. 6G) in accord with a previous
report (Falk et al., 2005). Association of
NrCAM and Npn-2 was also demonstrated
by antibody-induced coclustering on the
cell surface of the mouse neuroblastoma cell
line Neuro2A, which we found expresses
high levels of endogenous NrCAM, Npn-2,
and PlexinA3, a signaling subunit of the
Npn-2 receptor complex. Clustering of
Npn-2 using antibodies against its extracel-
lular region resulted in coclustering of NrCAM into caps (Fig. 6H)
and patches (Fig. 6I) on the Neuro2A cell surface, consistent with a
direct or indirect association. Coclustering was observed in 81% of
cells expressing both NrCAM and Npn2. Nonimmune IgG was used
as a control to ensure no cross-reactivity of secondary antibodies
(Fig. 6J,K).
In summary, Sema3F-induced growth cone collapse in embry-
onic thalamic neurons is attenuated by the loss of NrCAM. In addi-
tion, NrCAM associated with Npn-2 in embryonic brain and neural
cells, where it may function in the Sema3F receptor complex to repel
Figure 3. Rostral thalamic axons of NrCAM-null embryos are caudally shifted in the ventral and dorsal telencephalon at E15.5.
A–F, Anterogradely labeled rostral (DiA) and caudal (DiI) thalamic axons are shown in coronal sections in the VTe or DTe of WT and
NrCAM-null mutant embryos (E15.5) at the following locations: at the TE (A, D), VTe 500 m caudal to TE (B, E), and DTe 700 m
caudal to TE (C, F). Schemes at right depict the DiA and DiI injection sites and location of sections. G–J, Quantification of the
rostrocaudal distribution of rostral thalamic axons of WT and NrCAM-null embryos in the VTe (G, H) and in the DTe (I, J). Reference
point (0) corresponds to the TE. The frequency (percentage) of hemispheres containing DiA-labeled rostral thalamic axons ( y-axis)
is plotted versus section number relative to the TE along the rostrocaudal axis (normalized to total number of sections). The mean
distance (micrometers) of the caudal-most section from the TE containing DiA-labeled rostral thalamic axons was determined and
the SEM calculated for each genotype (*p  0.05, significant difference, t test). l, lateral; m, medial. Scale bar, 100 m.
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thalamic axons from Sema3F in the VTe important for DT axon
sorting.
Normal patterning of thalamic nuclei and cortical areas in
NrCAM mutant mice
Nissl staining of NrCAM-null mutant and WT littermates at P7
was used to assess the size and position of DT nuclei at equivalent
rostrocaudal levels (Takeuchi et al., 2007). Motor thalamic nuclei
(VA, VL), somatosensory VB nuclei, and the dLGN of NrCAM-
null mice were appeared normal in size and location compared
with WT on coronal sections (Fig. 7A–D). To compare the pat-
terning of neocortical areas, serotonin (5-HT) histochemistry
was performed on tangential (Fig. 7E,H–J) sections through
layer IV of flattened cortical hemispheres and coronal sections
(Fig. 7F,G,K,L) and of NrCAM-null and WT littermates at P7, as
described previously (Takeuchi et al., 2007). The location and
size of primary cortical areas [S1, V1, auditory cortex) and sec-
ondary somatosensory cortex in NrCAM mutants appeared to be
equivalent to WT (Fig. 7E–L). In coronal sections (Fig. 7F–L),
layer IV of S1 and V1 in NrCAM-null mice exhibited a normal
location and size. In particular, the length of V1 in coronal sec-
tions, measured by 5-HT staining at the level of the posterior
commissure, was approximately the same in NrCAM-null
(1117  74 m, n  6) and WT mice (1262  154 m, n  6).
Thalamocortical inputs to layer IV of S1 in NrCAM mutants also
segregated normally into a barrel field pattern characteristic of
WT (Fig. 7F,H, I,L). Thus, thalamic nuclei and cortical area pat-
terning appeared to be normal in NrCAM mutant mice.
Retinogeniculate axon targeting is unaffected by
NrCAM deletion
Ipsilateral retinal ganglion cell (RGC) axons project from the
ventrotemporal retina to the dLGN, where they form an ipsilat-
eral “patch” surrounded by contralateral axon terminations
Figure 4. Colocalization of NrCAM and neuropilin-2, and expression of Sema3F in the thalamocortical pathway. A–L, Double immunofluorescence staining for NrCAM and Npn-2 in WT embryos (E14.5)
showed high levels of expression and colocalization in the rostral DT (A–C) and lower levels of expression in the caudal DT (J–L; arrows indicate the TE) in coronal sections. D–F, Higher magnification of medial
third of the rostral DT, showing colocalization of Npn-2 and NrCAM on cells, and absence of Npn-2 from the extreme medial region. G–I, Higher magnification of the lateral region of the rostral DT showing
colocalization of Npn-2 and NrCAM on fibers. M–O, Colocalization of NrCAM and Npn-2 at the TE (arrows) at higher magnification. P, Q, In situ hybridization with a Sema3F antisense riboprobe in WT embryos
(E14.5) in horizontal sections. Sema3F transcripts were preferentially expressed in the VTe in a high-caudal to low-rostral gradient, and in the developing CP of the cortex. R, No labeling was observed with the
control sense riboprobe. S, Pixel density was measured along the rostrocaudal axis of the VTe in serial sections from 3 WT embryos (E14.5) using ImageJ Software, normalized to background. The data were fit to
a linear regression curve with an R 2 value of 0.8304. Abbreviations: l, lateral; m, medial. Scale bar: (A–C, J–L, P), 500 m; (R), 100 m; (D–I, M–O), 50 m.
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(Torborg et al., 2005). Most ipsilateral axons project early in
development (E14 –E16) (Williams et al., 2006). To visualize reti-
nogeniculate targeting and eye-specific segregation, RGC axons
of WT and NrCAM-null mutant mice were labeled by injection of
cholera toxin B-conjugated Alexa fluorophores (488, green; 594,
red) into right and left eyes at P10 (13 WT and 12 NrCAM-null
mutant mice). Their termination zones in the dLGN were visu-
alized at P12 (Fig. 8A,B), when most mouse ipsilateral projec-
tions have segregated into a patch in the
dorsomedial dLGN (Torborg et al., 2005).
The area of the ipsilateral patch and total
dLGN area were quantified by measure-
ment of pixels within designated areas of
fluorescent images using a multithreshold
protocol (Torborg et al., 2005; Stevens et
al., 2007). The area of the ipsilateral patch
relative to total dLGN area in NrCAM-
null mice was not significantly different
compared with WT mice at all threshold
levels (Fig. 8C; t test at each threshold
level, p  0.05). There were also no signif-
icant differences in dLGN area, location of
the ipsilateral patch, or length of the ipsi-
lateral patch in WT and NrCAM-null
mice (Fig. 8D). Thus, loss of NrCAM does
not appear to grossly perturb retino-
geniculate axon targeting.
Visual cortical function is altered in
NrCAM-null mutant mice
The aberrant migration of thalamic motor
and somatosensory afferents to the visual
cortex in NrCAM-null mutant mice sug-
gested a potential impact on cortical func-
tion. To investigate whether NrCAM loss
of function affects how the visual cortex
responds to visual stimuli, we recorded
VEPs in the binocular zone of the primary
visual cortex in awake WT and NrCAM-
null mutant littermates at P27. Con-
tralateral and ipsilateral retinogeniculate
projections terminate in the dLGN, where
they are relayed as thalamocortical projec-
tions to the binocular zone of V1 (Fig.
9A). VEPs can be induced by stimulating
both eyes with a full field visual stimulus
from a display monitor of reversing bars,
whose spatial frequency (cycles/degree) is
varied, to identify the stimulus that pro-
duces a maximal VEP response (Fig. 9B).
Stimulation of both eyes produced a
larger binocular visual response in WT
mice at 0.3 cpd compared with 0.05 cpd,
similar to what has been observed in the
129 mouse strain (Fig. 9B) (Yashiro et al.,
2009). In contrast, NrCAM-null mutants
responded strongly to visual stimulation
at the lower spatial frequency of 0.05 cpd
and more weakly at 0.3 cpd, indicative of
reduced visual acuity (Fig. 9B). This dif-
ference was quantified by plotting the
acuity ratio (VEP amplitude at 0.3/0.05
cpd), which showed a significant decrease
in NrCAM mutants (n  16) compared with WT (n  11) mice
(Fig. 9C; unpaired Student’s t test, p  0.0001). These results
demonstrate that NrCAM is required for the normal maturation
of cortical visual acuity.
Next, we examined the extent to which deletion of NrCAM
altered visual cortical inputs from the contralateral or ipsilateral
eye (relative to the recording electrode). For these experiments,
VEPs were examined when either the ipsilateral or contralateral
Figure 5. Rostral thalamic axons of neuropilin-2-null embryos (E15.5) are caudally shifted in the ventral and dorsal telenceph-
alon. A–F, Anterogradely labeled rostral (DiA) and caudal (DiI) thalamic axons are shown in coronal sections through the VTe and
DTe of heterozygous and homozygous Npn-2-null mutant embryos (E15.5) at the following locations: the TE (A, D), VTe 500 m
caudal to TE (B, E), and DTe 600 m caudal to TE (C, F). Schemes at right depict DiA and DiI injection sites and planes of sections.
Scale bar, 100 m. G–J, Quantification of the rostrocaudal distribution of rostral thalamic axons in Npn-2 heterozygotes and null
mutant embryos (E15.5) at the VTe (G, H) and DTe (I, J). The frequency (percentage) of hemispheres containing DiA-labeled rostral
thalamic axons ( y-axis) is plotted versus section number relative to the TE along the rostrocaudal axis (normalized to total number
of sections). Reference point (0) corresponds to the TE. The mean distances (micrometers) of the caudal-most section from the TE
containing DiA-labeled rostral thalamic axons in the VTe (H) or DTe (J) was determined for each genotype (*p  0.05, significant
difference, t test). l, lateral; m, medial.
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eye was covered to isolate eye-specific inputs to the binocular
zone of V1. Visual stimuli presented to the ipsilateral eye at a low
spatial frequency (0.05 cpd) produced similar VEP amplitude in
WT and NrCAM-null mutants (Fig. 9D). Visual stimuli at a
higher spatial frequency (0.3 cpd) produced a significantlyFigure 6. NrCAM is required for Sema3F-induced growth cone collapse in embryonic (E14.5)
thalamic neuron cultures. A, C, Representative examples of WT and NrCAM-null mutant non-
collapsed growth cones scored following 30 nM IgG treatment, fixed and stained with phalloi-
din. Scale bar, 5 m. B, D, Representative examples of WT and NrCAM-null mutant growth
cones scored following 30 nM Sema3F-Fc treatment, fixed and stained with phalloidin. Arrow
points to collapsed growth cone in B. Arrow points to noncollapsed growth cone in D. Scale bar,
5 m. E, NrCAM and Npn-2 colocalized in embryonic thalamic neurons within processes, soma,
and growth cones. Arrows indicate enrichment at tips of filopodia. F, Quantification of growth
cone collapse in thalamic neurons in response to Sema3F-Fc. Sema3F-Fc significantly increased
the percentage of collapsed growth cones in WT but not NrCAM-null mutant neurons compared
with nonimmune Ig treatment. Asterisks indicate significant differences in means ( p  0.05; t
test). n  number of growth cones scored. G, Coimmunoprecipitation of NrCAM and Npn-2
from E15.5 brain. Extracts of WT (E15.5) forebrain (1 mg) were immunoprecipitated (IP) with
NrCAM antibody (1 g) or normal rabbit IgG (nIg), separated by SDS-PAGE and immunoblotted
4
(IB) using antibodies to Npn-2 (135 kDa). Blots were reprobed with antibodies to NrCAM (145
kDa). H, I, Coclustering of NrCAM and Npn-2 on the cell surface of the mouse neuroblastoma cell
line Neuro2A. Clustering of Npn-2 on the cell surface was induced by treatment of live Neuro2A
cells with Npn-2 antibody complexes, then cells were fixed and immunostained for NrCAM
using NrCAM antibodies as described in Materials and Methods. Clustering of Npn-2, detected
with FITC-labeled secondary antibody (green) and coclustering of NrCAM detected with TRITC-
labeled secondary antibody (red) were observed by colocalization in caps (H) and patches (I) on
the cell surface in merged images (yellow). Differential interference contrast (DIC) of each cell is
shown to the right. J, K, Goat (J) and rabbit (K) nonimmune IgG were substituted for primary
antibodies as controls to ensure no cross-reactivity of secondary antibodies.
Figure 7. NrCAM-null mutant mice exhibit normal patterning of thalamic nuclei and cortical
areas. A–D, Nissl staining of coronal sections in WT (A, B) and NrCAM-null mutant (C, D) mice
(P7) shows normal size and locations of dorsal thalamic nuclei (VA/VL, VB, dLGN). E–L, Equiv-
alent area patterning in the cortex of WT (E–H) and NrCAM-null mutants (I–L) at P7 revealed by
5-HT immunoreactivity. Arrows delineate the barrel field in layer IV of S1 (F, K) and layer IV of V1
(G, L). White lines in J delineate V1 from an adjacent section. A1, primary auditory cortex. Scale
bar, 500 m.
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greater response in WT mice than at 0.05 cpd (t test, p  0.005),
but did not provoke an increased response in NrCAM mutants
(Fig. 9D). The ipsilateral-eye-evoked response at 0.3 cpd in
NrCAM mutants was significantly lower than in WT mice (Fig.
9D; paired Student’s t test, p  0.05). WT and NrCAM mutant
mice exhibited contralateral-eye responses similar in magnitude
to their binocular responses (data not shown).
Discussion
Here we identified a novel function for NrCAM and the Sema3F
receptor Npn-2 in guiding thalamocortical axon subpopulations
to specific neocortical areas at the ventral telencephalon, a pivotal
intermediate sorting target. Loss of NrCAM or Npn-2 caused
rostral embryonic thalamic axons to shift caudally in the VTe,
suggesting that NrCAM works in concert with Npn-2 to repel
thalamic axon contingents from Sema3F. Supporting this sub-
cortical mechanism, NrCAM formed a molecular complex with
Npn-2, and was required for growth cone collapse to Sema3F
in thalamic neuron cultures. Strikingly, loss of NrCAM caused
motor and somatosensory thalamic axons to misproject to the
visual cortex, altering the final topographic map. NrCAM loss
of function also profoundly altered responses of the visual
cortex to visual stimuli, revealed by decreased visual acuity
and differences in ocularity.
These findings support a new view of axon guidance in which
L1 family adhesion molecules interact with different repellent
axon guidance receptors, and potentially comprise a cell adhe-
sion molecule (“CAM”) code regulating topographic mapping of
thalamocortical axons. Our findings indicate that NrCAM inter-
action with Npn-2 mediates a posterior repellent response of
rostral thalamic axon subpopulations to Sema3F in the VTe, and
that this enables appropriate targeting of motor (VA/VL) and
somatosensory (VB) thalamic axon contingents to M1 and S1,
respectively. CHL1 interacts with a different receptor, Npn-1, to
mediate repulsion of thalamic axon contingents to a Sema3A
gradient in the VTe, which enables S1 targeting of VB axon con-
tingents (Wright et al., 2007), which may be distinct from those
regulated by NrCAM. L1 also interacts with Npn-1 and mediates
growth cone collapse to Sema3A (Castellani et al., 2000); how-
ever, loss of L1 alone does not cause thalamocortical targeting
errors (Wiencken-Barger et al., 2004; Demyanenko et al., 2010).
Instead, L1 cooperates with CHL1 for topographic targeting of
motor thalamic axon contingents from VA/VL to M1, as shown
by misprojection of motor thalamic axons to V1 in double mu-
tants (Demyanenko et al., 2010). L1 and CHL1 also associate with
different EphA receptors and mediate ephrinA5-induced growth
cone collapse (Demyanenko et al., 2010), so they might also func-
tionally interact with ephrinA/EphA guidance systems, which
regulate repellent axon guidance of motor thalamic axon contin-
gents at the VTe (Dufour et al., 2006). It is of singular interest that
deletion of NrCAM, CHL1, or both L1 and CHL1 result in caudal
mistargeting of different thalamic axon subpopulations to V1. In
Figure 8. Normal retinogeniculate axon targeting in NrCAM-null mice. Ipsilateral and
contralateral projections of retinal axons to the dLGN were labeled by injection of different
cholera toxin B-Alexa fluors into eyes at P10, and termination zones analyzed in the dLGN
at P12. A, B, Representative overlaid images of ipsilateral (red) and contralateral (green)
axons in the dLGN of WT (A) mice and NrCAM-null mutant (B) mice are shown. C, Quanti-
fication of the percentage of dLGN area occupied by the ipsilateral axon patch in WT (n 
13) and NrCAM-null mutants (n  12) indicated no significant differences for each thresh-
old level ( p  0.05, t test). D, Table indicates no quantitative difference in mean dLGN
area, or mean location or length of the ipsilateral patch in the dLGN for WT and NrCAM-null
mice ( p  0.05, t test).
Figure 9. Genetic deletion of NrCAM alters visually driven responses in primary visual cortex.
A, Schematic demonstrating basic wiring and the recording of VEPs in binocular visual cortex. B,
Representative VEPs in P27 WT or NrCAM-null mutant mice (KO) evoked by binocular presen-
tations of sinusoidal gratings at 0.05 or 0.3 cpd. C, Quantification of the binocularly driven VEPs
demonstrates that, unlike WT mice, NrCAM-null mutant mice have larger VEP responses to
stimuli presented at 0.05 cpd than at 0.3 cpd (t test, p 0.0001). D, Compared with NrCAM-null
mutant mice, WT mice exhibit a larger VEP driven by stimulation of the ipsilateral at 0.3 cpd eye
(WT 0.05 cpd vs 0.3 cpd paired t test, p  0.005; WT vs NrCAM-null mutant t test, p  0.05). No
differences in ipsilateral VEP amplitude were observed at 0.05 cpd. Error bars represent SEM.
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VTe gradients of ephrinA/EphA control sorting of thalamocorti-
cal axon contingents to M1 (Dufour et al., 2003), Netrin1/DCC
provide a counterforce (Bonnin et al., 2007; Powell et al., 2008),
and Neuregulin-1 guides axons across a corridor (López-Bendito
et al., 2006). Studies from our group have given rise to a concept
that guidance is to semaphorin gradients in the VTe. Because
NrCAM, L1, and CHL1 are expressed in different but overlapping
patterns in the embryonic DT, they are likely to control guid-
ance of subpopulations of thalamic axons. Differential expres-
sion, coupled with the ability of NrCAM and L1/CHL1 to
mediate Sema3F or Sema3A responses through Npn-1/2 re-
ceptor complexes, respectively, suggests that L1-CAM interac-
tions may serve to increase the specificity of repellent guidance
responses in different thalamocortical axon subpopulations
within the VTe necessary for correct pathfinding to area-
specific cortical targets.
Our results do not exclude a role for NrCAM in regulating
axon guidance within the neocortex, where Sema3F (shown here)
and Sema3A (Wright et al., 2007) are expressed. For example,
Sema3F was recently shown to regulate axonal projections of
dopaminergic neurons in the prefrontal cortex (Kolk et al., 2009)
and to specify axon map topography in the olfactory bulb
(Takeuchi et al., 2010). By analogy, ephrinAs have cortical and
subcortical functions, serving as cues for mapping dLGN axons
within the visual cortex (Cang et al., 2005), as well as regulating
thalamic axon guidance in the VTe (Dufour et al., 2006). NrCAM
expressed in deep layer cortical neurons might also affect corti-
cothalamic axon guidance, which is postulated to reciprocally
influence thalamocortical axon guidance (Molnár and Blake-
more, 1995).
Our results implicate NrCAM in repellent responses to the
Sema3F gradient in the VTe to regulate thalamic axon sorting.
Among the secreted class 3 semaphorins (Sema3A-G) only Sema3F
(shown here) and Sema3A (Wright et al., 2007) are expressed at
significant levels in the VTe at E15.5 (Brain Gene Expression
Map (BGEM), St. Jude Children’s Research Hospital: http://
www.stjudebgem.org; and Allen Institute for Brain Science: http://
developingmouse.brain-map.org). Although NrCAM can mediate
Sema3B signaling through Npn-2, which is important in positioning
the anterior commissure (Falk et al., 2005), Sema3B is not expressed
in the VTe at E15.5, which has been shown in Sema3B bacterial
artificial chromosome (BAC) transgenic mice carrying an enhanced
green fluorescent protein reporter (Gong et al., 2003). However,
certain transmembrane semaphorins (Sema4A, C-G, Sema5B, and
Sema6A-D) are expressed in the E15.5 VTe (Allen Institute for Brain
Science: http://developingmouse.brain-map.org), where they might
influence thalamic axon guidance.
Our findings that the loss of NrCAM impairs visual acuity and
ocularity indicates that visual cortical wiring critically depends
upon NrCAM expression. The preferential decrease in ipsilateral
visual responses could be due to (1) fewer or weaker ipsilateral-
eye inputs to the visual cortex binocular zone, (2) a dispersion of
ipsilateral-eye inputs to a broader region of the visual cortex, (3)
mistargeting of ipsilateral eye inputs, and/or (4) other defects in
the retinogeniculocortical pathway. Notably, many aspects of vi-
sual system development appeared grossly normal in the absence
of NrCAM, including the retinogeniculate axon targeting, eye-
specific segregation within the dLGN, and areal targeting of
geniculocortical pathways. In NrCAM-null mice, a subpopula-
tion of contralaterally projecting axons from the retina fails to
cross the chiasm and instead misprojects ipsilaterally at later
stages (E17-P0) (Falk et al., 2005; Williams et al., 2006) than when
most ipsilateral axons project to the dLGN (E14 –E16) (Falk et al.,
2005; Williams et al., 2006). Since NrCAM-null mutants did not
show evidence for gross mistargeting of ipsilateral or contralat-
eral projections within the dLGN, when analyzed postnatally,
retinal axons that misproject at the chiasm may represent a rela-
tively small population; alternatively, these axons may not reach
the dLGN or are eliminated. Our observation of reduced ipsilat-
eral eye responsiveness in the absence of NrCAM also does not
accord with an excess of ipsilateral input to the dLGN. It is more
likely that thalamocortical errors, rather than retinogeniculate
errors contribute to the aberrant visual acuity. For example, mo-
tor and somatosensory thalamic axons that mistarget to the visual
cortex in NrCAM-deficient mice might compete with dLGN in-
puts within layer IV, disrupting ipsilateral eye visual responses. It
is unlikely that the ectopic projections observed in NrCAM-null
mice at P5–P8 are corrected in adulthood, restoring visual func-
tion. Thalamocortical connectivity is established by P4 –P8, as
shown in the mouse somatosensory cortex (Agmon et al., 1995),
and impaired visual evoked responses of NrCAM-null mutants
were clearly evident at P27. Although future investigations are
needed to identify the precise mechanisms involved, it is clear
that the loss of NrCAM severely disrupts normal visual process-
ing in a mouse model.
The aberrant thalamocortical mapping and visual cortical re-
sponses observed in NrCAM-deficient mice are consistent with
abnormal visual function (Milne et al., 2009a,b; Isler et al., 2010)
and altered thalamocortical connectivity in both visual (Mizuno
et al., 2006) and sensorimotor systems (Mostofsky et al., 2009) in
ASD. Such deficits might reflect impaired functional interaction
of NrCAM with Npn-2 during development, resulting in axon
guidance errors and abnormal visual circuitry in the cortex. In
this regard it is interesting that Npn-2 gene polymorphisms have
been associated with autism in a Chinese Han population (Wu et
al., 2007). Aberrant visual connectivity and cortical responses
may also contribute to social impairments characteristically as-
sociated with ASD. Loss of sociability and deficits in reversal
learning in NrCAM-null mice (Moy et al., 2009a) recapitulate
aspects of the ASD phenotype, thus further investigation on the
developmental role of NrCAM may illuminate the abnormal cir-
cuitry underlying visual and social deficits found in ASD and
other disorders.
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